AKURA MEDICAL'S STORY

Next-generation clot removal

With an estimated 900,000 cases and 100,000 deaths annually in the United States, venous thromboembolism is the third most common cardiovascular cause of death, trailing only heart attacks and strokes. Existing treatments have significant limitations and requirements – high bleeding risks, lengthy treatment times, procedural complexities and extended hospital stays.

Akura Medical’s flagship product — the Akura Thrombectomy Catheter System — offers a unique solution that aims to address four key limitations of current-generation devices, namely navigation, target clot visualization, catheter clogging and tracking case progress.

Boasting a low-profile, steerable sheath, this user-friendly system incorporates bidirectional steering designed to enable physicians to precisely navigate complex vasculature. Physicians can deliver a small dose of contrast at any time during the procedure to visualize the area of interest and address clots without the need to cross them. The integrated aspiration and maceration technology, complemented by real-time data from pressure sensors, is designed to enable efficient removal of target clots and allow operators to detect changes in vascular pressure once a clot is removed.